Aktie 300878 ZHEJIANG WECOME PHARMACEUTICAL COMPANY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Zhejiang Wecome Pharmaceutical Company Limited

Aktien

300878

CNE1000047P9

300878

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 21.06.2024 		% 5 Tage % 1. Jan.
14,74 CNY +2,01 % Intraday Chart für Zhejiang Wecome Pharmaceutical Company Limited -1,99 % -41,90 %
22.05. Zhejiang Wecome Pharmaceutical Company Limited kündigt letzte Bardividende auf A-Aktien für das Jahr 2023 an, zahlbar am 29. Mai 2024 CI
28.04. Zhejiang Wecome Pharmaceutical Company Limited meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Zhejiang Wecome Pharmaceutical Company Limited Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Zhejiang Wecome Pharmaceutical Company Limited's Equity Buyback Plan announced on February 7, 2024.
Zhejiang Wecome Pharmaceutical Company Limited's Equity Buyback announced on February 7, 2024, has closed with 2,739,026 shares, representing 1.89% for CNY 50 million.
Zhejiang Wecome Pharmaceutical Company Limited announces an Equity Buyback for CNY 50 million worth of its shares.
Zhejiang Wecome Pharmaceutical Company Limited authorizes a Buyback Plan.
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Certain A Shares of Zhejiang Wecome Pharmaceutical Company Limited are subject to a Lock-Up Agreement Ending on 24-AUG-2023.
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022
Zhejiang Wecome Pharma to Issue $95 Million Convertible Bonds
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Hangzhou Haishan Pharmaceutical Equipment Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Wecome Pharmaceutical Company Limited
Zhejiang Wecome Pharmaceutical Company Limited Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 17 June 2022
Zhejiang Wecome Pharmaceutical Company Limited Approved Cash Dividend for the Year 2021
Zhejiang Wecome Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2021
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 300878 Aktie
  4. Nachrichten Zhejiang Wecome Pharmaceutical Company Limited
  5. Andere Sprachen